MMV Request for Proposal: Development of low dose primaquine tablets in a child-friendly formulation
Medicine for Malaria Venture (MMV) is seeking proposals from eligible manufacturers to develop and deliver dispersible, taste-masked paediatric formulations of primaquine. Applications deadline February 10, 2020.